Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RG
Regentis Biomaterials Ltd.
RGNT
Mkt Cap
$10.5M
Volume
22.80K
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RG
RGNT
RG
Regentis Biomaterials Ltd.
RGNT
News
·
Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is Trending
Mkt Cap
$10.5M
Volume
22.80K
Next Earnings
N/A
Chart
Financials
Earnings
News
About
Insider
Filings
Regentis Biomaterials Slips 9% After Soaring 506% On Monday — Here's Why RGNT Stock Is Trending
Regentis Biomaterials (RGNT) surged 506% intraday on Monday to $9.40 before slipping 9.15% to $8.54 in after-hours trading. The volatility followed the company's announcement that it withdrew its Form F-1 registration statement and decided not to pursue a planned public offering. The regenerative medicine company, which develops tissue repair solutions including its Gelrin platform for orthopedic treatments, has a market cap of $48.69 million.
Benzinga · Jun 16, 2026
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
Regentis Biomaterials successfully completed its initial public offering, raising $10 million by selling 1,250,000 ordinary shares at $8.00 per share. The company plans to use proceeds for product development, specifically advancing its GelrinC cartilage injury therapeutic.
Benzinga · Dec 5, 2025
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
RG
RGNT
Regentis Biomaterials Ltd.
Buy
Sell
Market
Limit
Soon
RGNT
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any RGNT yet.
Related Tickers
Earnings